alanine has been researched along with liraglutide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bojsen-Møller, KN; Deacon, CF; Hansen, AE; Hansen, ML; Holst, JJ; Johannesen, HH; Keller, SH; Kjaer, A; Klausen, TL; Löfgren, J; Loft, A; Madsbad, S; Martinussen, C; Svane, MS; Wewer Albrechtsen, NJ | 1 |
1 other study(ies) available for alanine and liraglutide
Article | Year |
---|---|
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight.
Topics: Adult; Alanine; Amino Acids; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin; Liraglutide; Liver; Male; Middle Aged; Overweight | 2022 |